Effort-based decision making: A novel approach for assessing motivation in schizophrenia

Schizophrenia Bulletin

Volumn 41, Issue 5, 2015, Pages 1035-1044

  Green, Michael F ^a,b   Horan, William P ^a,b   Barch, Deanna M ^c   Gold, James M ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trials; Effort based decision making; Motivation; Negative symptoms; Schizophrenia

Indexed keywords

ALERTNESS; ARTICLE; ATTENTION; BRIEF PSYCHIATRIC RATING SCALE; CALGARY DEPRESSION SCALE; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DECISION MAKING; EFFORT BASED DECISION MAKING; HAND GRIP; HUMAN; LEARNING; MOTIVATION; NEGATIVE SYNDROME; NONHUMAN; PHONEME; PHYSICAL ACTIVITY; PLANNING; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; REWARD; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TASK PERFORMANCE; TEST RETEST RELIABILITY; VISUAL MEMORY; WORKING MEMORY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY;

DECISION MAKING; HUMANS; MOTIVATION; NEUROPSYCHOLOGICAL TESTS; REWARD; SCHIZOPHRENIA; TASK PERFORMANCE AND ANALYSIS;

EID: 84943169141     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbv071     Document Type: Article

References (49)

1. Blanchard JJ, Cohen AS. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull. 2006;32:238-245.
2. Kirkpatrick B, Fenton W, Carpenter WT, Marder SR. The NIMH-MATRICS Consensus Statement on Negative Symptoms. Schizophr Bull. 2006;32:296-303.
3. Rassovsky Y, Horan WP, Lee J, Sergi MJ, Green MF. Pathways between early visual processing and functional outcome in schizophrenia. Psychol Med. 2011;41:487-497.
4. Horan WP, Kring AM, Blanchard JJ. Anhedonia in schizophrenia: a review of assessment strategies. Schizophr Bull. 2006;32:259-273.
5. Green MF, Hellemann G, Horan WP, Lee J, Wynn JK. From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Arch Gen Psychiatry. 2012;69:1216-1224.
6. Davis MC, Horan WP, Marder SR. Psychopharmacology of the negative symptoms: current status and prospects for progress. Eur Neuropsychopharmacol. 2014;24:788-799.
7. Marder SR, Alphs L, Anghelescu IG, et al. Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia. Schizophr Res. 2013;150:328-333.
8. Marder SR, Daniel DG, Alphs L, Awad AG, Keefe RS. Methodological issues in negative symptom trials. Schizophr Bull. 2011;37:250-254.
9. Kring AM, Gur RE, Blanchard JJ, Horan WP, Reise SP. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation. Am J Psychiatry. 2013;170:165-172.
10. Kirkpatrick B, Strauss GP, Nguyen L, et al. The brief negative symptom scale: psychometric properties. Schizophr Bull. 2011;37:300-305.
11. Young JW, Markou A. Translational rodent paradigms to investigate neuromechanisms underlying behaviors relevant to amotivation and altered reward processing in schizophrenia. Schizophr Bull. In press.
12. Shenhav A, Botvinick MM, Cohen JD. The expected value of control: an integrative theory of anterior cingulate cortex function. Neuron. 2013;79:217-240.
13. Walton ME, Rudebeck PH, Bannerman DM, Rushworth MF. Calculating the cost of acting in frontal cortex. Ann N Y Acad Sci. 2007;1104:340-356.
14. Goldstein RZ, Tomasi D, Alia-Klein N, et al. Subjective sensitivity to monetary gradients is associated with frontolimbic activation to reward in cocaine abusers. Drug Alcohol Depend. 2007;87:233-240.
15. Barkley-Levenson E, Galván A. Neural representation of expected value in the adolescent brain. Proc Natl Acad Sci USA. 2014;111:1646-1651.
16. Prévost C, Pessiglione M, Météreau E, Cléry-Melin ML, Dreher JC. Separate valuation subsystems for delay and effort decision costs. J Neurosci. 2010;30:14080-14090.
17. Carter RM, Meyer JR, Huettel SA. Functional neuroimaging of intertemporal choice models: A review. J Neurosci Psychol Econ 2010;3:27-45.
18. McGuire JT, Botvinick MM. Prefrontal cortex, cognitive control, and the registration of decision costs. Proc Natl Acad Sci USA. 2010;107:7922-7926.
19. Botvinick M, Braver T. Motivation and cognitive control: from behavior to neural mechanism. Annu Rev Psychol. 2015;66:83-113.
20. Padoa-Schioppa C, Cai X. The orbitofrontal cortex and the computation of subjective value: consolidated concepts and new perspectives. Ann N Y Acad Sci. 2011;1239:130-137.
21. Rudebeck PH, Murray EA. Dissociable effects of subtotal lesions within the macaque orbital prefrontal cortex on reward-guided behavior. J Neurosci. 2011;31:10569-10578.
22. Treadway MT, Buckholtz JW, Cowan RL, et al. Dopaminergic mechanisms of individual differences in human effort-based decision-making. J Neurosci. 2012;32:6170-6176.
23. Schmidt L, Lebreton M, Cléry-Melin ML, Daunizeau J, Pessiglione M. Neural mechanisms underlying motivation of mental versus physical effort. PLoS Biol. 2012;10:e1001266.
24. Rudebeck PH, Walton ME, Smyth AN, Bannerman DM, Rushworth MF. Separate neural pathways process different decision costs. Nat Neurosci. 2006;9:1161-1168.
25. Hosking JG, Cocker PJ, Winstanley CA. Dissociable contributions of anterior cingulate cortex and basolateral amygdala on a rodent cost/benefit decision-making task of cognitive effort. Neuropsychopharmacology. 2014;39:1558-1567.
26. Croxson PL, Walton ME, Boorman ED, Rushworth MF, Bannerman DM. Unilateral medial frontal cortex lesions cause a cognitive decision-making deficit in rats. Eur J Neurosci. 2014;40:3757-3765.
27. Croxson PL, Walton ME, O'Reilly JX, Behrens TE, Rushworth MF. Effort-based cost-benefit valuation and the human brain. J Neurosci. 2009;29:4531-4541.
28. Fervaha G, Graff-Guerrero A, Zakzanis KK, Foussias G, Agid O, Remington G. Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making. J Psychiatr Res. 2013;47:1590-1596.
29. Barch DM, Treadway MT, Schoen N. Effort, anhedonia, and function in schizophrenia: reduced effort allocation predicts amotivation and functional impairment. J Abnorm Psychol. 2014;123:387-397.
30. Treadway MT, Peterman JS, Zald DH, Park S. Impaired effort allocation in patients with schizophrenia. Schizophr Res. 2015;161:382-385.
31. Gold JM, Strauss GP, Waltz JA, Robinson BM, Brown JK, Frank MJ. Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biol Psychiatry. 2013;74:130-136.
32. Docx L, de la Asuncion J, Sabbe B, et al. Effort discounting and its association with negative symptoms in schizophrenia. Cogn Neuropsychiatry. 2015;20:172-185.
33. Hartmann MN, Hager OM, Reimann AV, et al. Apathy but not diminished expression in schizophrenia is associated with discounting of monetary rewards by physical effort. Schizophr Bull. 2015;41:503-512.
34. Wolf DH, Satterthwaite TD, Kantrowitz JJ, et al. Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures. Schizophr Bull. 2014;40:1328-1337.
35. Gold JM, Kool W, Botvinick MM, Hubzin L, August S, Waltz JA. Cognitive effort avoidance and detection in people with schizophrenia. Cogn Affect Behav Neurosci. 2015;15:145-154.
36. Strauss GP, Waltz JA, Gold JM. A review of reward processing and motivational impairment in schizophrenia. Schizophr Bull. 2014;40 (suppl 2):S107-S116.
37. Randall PA, Pardo M, Nunes EJ, et al. Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences. PLoS One. 2012;7:e47934.
38. Salamone JD, Correa M, Nunes EJ, Randall PA, Pardo M. The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond. J Exp Anal Behav. 2012;97:125-146.
39. Randall PA, Lee CA, Podurgiel SJ, et al. Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms. Int J Neuropsychopharmacol. In press.
40. Gard DE, Sanchez AH, Cooper K, Fisher M, Garrett C, Vinogradov S. Do people with schizophrenia have difficulty anticipating pleasure, engaging in effortful behavior, or both? J Abnorm Psychol. 2014;123:771-782.
41. Green MF, Lee J, Ochsner KN. Adapting social neuroscience measures for schizophrenia clinical trials, Part 1: ferrying paradigms across perilous waters. Schizophr Bull. 2013;39:1192-1200.
42. Green MF, Nuechterlein KH, Gold JM, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry. 2004;56:301-307.
43. Gold JM, Waltz JA, Frank MJ. Effort cost computation in schizophrenia: A commentary on the recent literature. Biol Psychiatry. (Under review).
44. Horan WP, Reddy LF, Barch DM, et al. Effort-Based decision making paradigms for clinical trials in schizophrenia: Part 2 - external validity and correlates. Schizophr Bull. In press.
45. Reddy LF, Horan WP, Barch DM, et al. Effort-based decision making paradigms for clinical trials in schizophrenia: Part 1 - Psychometric characteristics of five paradigms. Schizophr Bull. In press.
46. Salamone JD, Correa M, Farrar AM, Nunes EJ, Pardo M. Dopamine, behavioral economics, and effort. Front Behav Neurosci. 2009;3:13.
47. Salamone JD, Correa M. The mysterious motivational functions of mesolimbic dopamine. Neuron. 2012;76:470-485.
48. Farrar AM, Segovia KN, Randall PA, et al. Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors. Neuroscience. 2010;166:1056-1067.
49. Trifilieff P, Feng B, Urizar E, et al. Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation. Mol Psychiatry. 2013;18:1025-1033.